Bayer Weighs Structural Changes But Rules Out Three-Way Split

[ad_1] Updated Nov. 8, 2023 5:34 am ET Bayer Chief Executive Bill Anderson said he is looking at options to overhaul the company’s structure and remove multiple layers of management…

Germany’s Bayer Says it Won a Roundup Cancer Trial in California

[ad_1] German chemical giant Bayer AG said it won a trial in a US lawsuit brought by a man who said exposure to its Roundup herbicide caused him to develop…

Bayer Monsanto: PCB maker ordered to pay $857m for toxic leaks

[ad_1] A US jury orders chemical giant Monsanto to pay out to seven people in the state of Washington. [ad_2] Source link

Bayer chief blames thin drug pipeline on ‘years of under-investment’

[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bayer’s chief executive has blamed an “old chemistry mindset”…

Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills

[ad_1] BERLIN—Bayer Chief Executive Bill Anderson said the company would bounce back quickly from a recent spate of bad news, and warned that a breakup of the pharmaceutical and agricultural…

Bayer calls bond investors after raft of bad news

[ad_1] NEW YORK: Bayer held a call with investors after a raft of bad news led some of them to question whether the German group had been upfront about its…

Exclusive: Bayer holds call with bond investors after raft of bad news

[ad_1] Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo Acquire Licensing Rights Nov…

Stocks Extend Rally, Boosted by AI Optimism

[ad_1] Nvidia shares gain, and Microsoft hits a new all-time high as investor enthusiasm for artificial intelligence takes center stage again. [ad_2] Source link

Bayer ordered to pay $1.56 billion in latest US trial loss over Roundup weedkiller

[ad_1] Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay Acquire Licensing Rights Nov 19…

Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

[ad_1] Updated Nov. 20, 2023 3:16 pm ET Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and…